Hester Biosciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Hester Biosciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 49.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23
What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11
Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hester Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 3,164 | 235 | 431 | 666 | N/A |
| 6/30/2024 | 3,057 | 194 | N/A | N/A | N/A |
| 3/31/2024 | 3,112 | 189 | 237 | 481 | N/A |
| 12/31/2023 | 2,992 | 185 | N/A | N/A | N/A |
| 9/30/2023 | 3,106 | 257 | -52 | 228 | N/A |
| 6/30/2023 | 3,164 | 285 | N/A | N/A | N/A |
| 3/31/2023 | 2,782 | 266 | -542 | 236 | N/A |
| 12/31/2022 | 2,723 | 298 | N/A | N/A | N/A |
| 9/30/2022 | 2,514 | 271 | -1,404 | 52 | N/A |
| 6/30/2022 | 2,379 | 308 | N/A | N/A | N/A |
| 3/31/2022 | 2,466 | 393 | -870 | 87 | N/A |
| 12/31/2021 | 2,504 | 413 | N/A | N/A | N/A |
| 9/30/2021 | 2,501 | 451 | 219 | 357 | N/A |
| 6/30/2021 | 2,397 | 412 | N/A | N/A | N/A |
| 3/31/2021 | 2,177 | 344 | 173 | 581 | N/A |
| 12/31/2020 | 1,989 | 275 | N/A | N/A | N/A |
| 9/30/2020 | 1,917 | 267 | -385 | 408 | N/A |
| 6/30/2020 | 1,848 | 265 | N/A | N/A | N/A |
| 3/31/2020 | 1,878 | 292 | -367 | 368 | N/A |
| 12/31/2019 | 1,956 | 396 | N/A | N/A | N/A |
| 9/30/2019 | 1,906 | 409 | 128 | 598 | N/A |
| 6/30/2019 | 1,890 | 413 | N/A | N/A | N/A |
| 3/31/2019 | 1,842 | 416 | 241 | 467 | N/A |
| 3/31/2018 | 1,373 | 256 | N/A | 380 | N/A |
| 3/31/2017 | 1,232 | 235 | N/A | 348 | N/A |
| 3/31/2016 | 1,009 | 192 | N/A | 188 | N/A |
| 3/31/2015 | 900 | 136 | N/A | 198 | N/A |
| 3/31/2014 | 690 | 95 | N/A | 94 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HESTERBIO's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if HESTERBIO's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if HESTERBIO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if HESTERBIO's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if HESTERBIO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HESTERBIO's Return on Equity is forecast to be high in 3 years time